Age: 35.0
Sex: F
Vaccine: COVID19
Symptoms: Exposure during pregnancy, Headache, Nasal congestion, Nasopharyngitis, Vaccination site erythema
Clinical narrative: Patient has a cold; Congestion; The injection site is magnetized, I can stick a magnet to the injection site; Injection site is the size of a dime; Injection site is red; Injection site is swollen; Headache; Patient is 31 weeks pregnant; Injection site left arm was sore.; This spontaneous prospective pregnancy case was reported by a consumer and describes the occurrence of NASOPHARYNGITIS (Patient has a cold), NASAL CONGESTION (Congestion), VACCINATION SITE REACTION (The injection site is magnetized, I can stick a magnet to the injection site), VACCINATION SITE PAPULE (Injection site is the size of a dime) and EXPOSURE DURING PREGNANCY (Patient is 31 weeks pregnant) in a 35-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 088D21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 18-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. The patient's last menstrual period was on 21-Jan-2021 and the estimated date of delivery was 28-Oct-2021. On 18-Aug-2021, the patient experienced EXPOSURE DURING PREGNANCY (Patient is 31 weeks pregnant) and VACCINATION SITE PAIN (Injection site left arm was sore.). On 26-Aug-2021, the patient experienced NASOPHARYNGITIS (Patient has a cold), NASAL CONGESTION (Congestion), VACCINATION SITE REACTION (The injection site is magnetized, I can stick a magnet to the injection site), VACCINATION SITE PAPULE (Injection site is the size of a dime), VACCINATION SITE ERYTHEMA (Injection site is red), VACCINATION SITE SWELLING (Injection site is swollen) and HEADACHE (Headache). The patient received mRNA-1273 (Moderna COVID-19 Vaccine) beginning around the  twenty-ninth week of the pregnancy.  On 18-Aug-2021, EXPOSURE DURING PREGNANCY (Patient is 31 weeks pregnant) had resolved. At the time of the report, NASOPHARYNGITIS (Patient has a cold), NASAL CONGESTION (Congestion), VACCINATION SITE REACTION (The injection site is magnetized, I can stick a magnet to the injection site), VACCINATION SITE PAPULE (Injection site is the size of a dime), VACCINATION SITE PAIN (Injection site left arm was sore.), VACCINATION SITE ERYTHEMA (Injection site is red), VACCINATION SITE SWELLING (Injection site is swollen) and HEADACHE (Headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   The patient stated that she is 31 weeks pregnant currently, with a due date of 28 October 2021.  No concomitant product use was provided by the reporter.   No treatment medications were reported.   Most recent FOLLOW-UP information incorporated above includes: On 26-Aug-2021: Significant follow-up. Pregnancy details updated. New event-vaccination exposure during pregnancy added.; Sender's Comments: This is a case of product exposure during pregnancy with associated AEs for this 3 5-year old female. Patient will not be contacted for further monitoring of AEs during the pregnancy.